The purpose of this notice is to correct the key dates section of RFA-NS-22-040 "BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed)".
Find Funding Opportunities
NIH Extramural Response to Natural Disasters and Other Emergencies
In emergency situations, the NIH’s immediate concern is for the health and safety of people and animals in the programs we oversee. Visit the NIH Extramural Response to Natural Disasters and Other Emergencies web page for biomedical research community resources, including NIH Guide Notices and other information of particular relevance to investigators and their institutions, links to web pages listing NIH’s response to certain major events (past and present); and links to similar web sites from other Federal agencies.
COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements
All NINDS-related notices of funding opportunities (NOFOs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed. Search the Closed Opportunities tab to find expired opportunities. Search the Notices tab to find all Notices.
Learn more about award types and program directors and managers.
NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!
For more focused results add quotes to indicate parameters. Example format: "search term".
Notice of Correction to Key Dates for RFA-NS-22-040 "BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed)"
Expiration Date: Sábado, Enero 1, 2028
NOFO Number: NOT-NS-22-112
Lunes, Agosto 8, 2022
Notice Type: NOT
Notice of Change to the title of PAR-22-181, "NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
Expiration Date: Sábado, Enero 1, 2028
NOFO Number: NOT-NS-22-111
Jueves, Agosto 4, 2022
Notice Type: NOT
The purpose of this notice is to inform applicants of a change to the title to reflect NINR's participation in PAR-22-181 "NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)".
Notice of NINR Participation in PAR-22-181, "NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
Expiration Date: Sábado, Enero 1, 2028
NOFO Number: NOT-NR-22-016
Jueves, Agosto 4, 2022
Notice Type: NOT
This Notice informs potential applicants of the National Institute of Nursing Research (NINR) participation, effective immediately, in the funding opportunity announcement (FOA) PAR-22-181, NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional).
Notice of Correction to Award Conditions for NOT-NS-23-001: "Notice of Special Interest (NOSI): COVID-19 Related Revisions to NINDS ADRD Human Subjects Cooperative Agreement Programs"
Expiration Date: Sábado, Enero 1, 2028
NOFO Number: NOT-NS-23-020
Martes, Agosto 2, 2022
Notice Type: NOT
Correcting total vs direct cost in the text.
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain(RM1 Clinical Trial Optional)
Expiration Date: Sábado, Enero 1, 2028
NOFO Number: NOT-NS-23-009
Viernes, Julio 29, 2022
Notice Type: NOT
NOITP
Notice of Correction to Announcement Type for "PAR-22-142: NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)"
Expiration Date: Sábado, Enero 1, 2028
NOFO Number: NOT-NS-22-120
Jueves, Julio 28, 2022
Notice Type: NOT
This FOA should be a reissue of PAR-21-236.
Notification to the community of change in maximum salary provided by NINDS K award mechanisms for clinician-scientists.
Expiration Date: Sábado, Enero 1, 2028
NOFO Number: NOT-NS-23-005
Miércoles, Julio 27, 2022
Notice Type: NOT
This notice informs the public that, effective in Fiscal Year 2022 (FY2022), NINDS will raise the maximum salary support provided to clinician-scientists on Career Development (K) awards for the related funding opportunity announcements listed above. The new cap on salary provided for clinician-scientists
supported by individual, mentored K awards (K01, K08, K22, K23, K99) will be $125,000;
supported by individual, independent K awards (K02) will be $150,000;
supported by institutional K awards (K12) will be $115,000.
Notice of Change to the maximum salary for clinician-scientists for PAR-21-153 and PAR-21-234 NINDS faculty Development Award to Promote Diversity in Neuroscience Research (K01)
Expiration Date: Sábado, Enero 1, 2028
NOFO Number: NOT-NS-22-107
Martes, Julio 26, 2022
Notice Type: NOT
The purpose of this notice is to inform potential applicants of a change to the maximum salary for clinician scientists for PAR-21-153 "NINDS faculty Development Award to Promote Diversity in Neuroscience Research (K01 Clinical Trial Required)" and PAR-21-234 "NINDS faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)". Effective in FY 2022, NINDS will raise the maximum salary support provided to clinician-scientists on Career Development (K) awards. The new cap on salary provided for clinician-scientists supported by the K01 will be $125,000.00.
Notice of Change to the maximum salary for clinician-scientists for PAR-21-327 and PAR-21-328 Career Transition Award for NINDS Intramural Clinician-Scientists (K22)
Expiration Date: Sábado, Enero 1, 2028
NOFO Number: NOT-NS-22-108
Martes, Julio 26, 2022
Notice Type: NOT
The purpose of this notice is to inform potential applicants of a change to the maximum salary for clinician scientists for PAR-21-327 "Career Transition Award for NINDS Intramural Clinician-Scientists (K22 - Clinical Trial Required)" and PAR-21-328 "Career Transition Award for NINDS Intramural Clinician-Scientists (K22 - Clinical Trial Not Allowed)". Effective in FY 2022, NINDS will raise the maximum salary support provided to clinician-scientists on Career Development (K) awards. The new cap on salary provided for clinician-scientists supported by the K01 will be $125,000.00.
Notice of Change to the Maximum Salary for Clinician-Scientists for PAR-22-022 NINDS Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00)
Expiration Date: Sábado, Enero 1, 2028
NOFO Number: NOT-NS-22-109
Martes, Julio 26, 2022
Notice Type: NOT
The purpose of this notice is to inform potential applicants of a change to the maximum salary for clinician scientists for PAR-22-022 "NINDS Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)". Effective in FY 2022, NINDS will raise the maximum salary support provided to clinician-scientists on Career Development (K) awards. The new cap on salary provided for clinician-scientists supported by the K99 will be $125,000.00.